A lung-cancer treatment and medication to help patients with high cholesterol are being added to the Pharmaceutical Benefits Scheme, saving Australians thousands of dollars.
"These listings with help the thousands of Australians and their families fighting lung cancer and the devastating impact of heart disease," Health Minister Greg Hunt said on Sunday.
Listing immunotherapy drug Keytruda on the PBS will give more than 1000 Australians with untreated lung cancer access to the discounted medication.
The pharmaceutical company behind the drug, MSD Australia, says the listing if of the "utmost importance" to patients with advanced lung cancer.
Repatha, a drug used to treat high cholesterol that works differently from statin treatment, is also being listed on the PBS.
